



































In 2009, 23% 
of new HIV 
infections in the 
US were among 
women. 
Black and Latina 
women are 
disproportionately 
aff ected at all 
stages of HIV 
infection 
compared with 
women of other 
races/ethnicities. 
For women, the 
most common 





injection drug use. 
August 2011 
According to 2009 HIV surveillance data, women1 
represented 24% of all diagnoses of HIV infection 
among United States (US) adults and adolescents 
in 40 states with long-established, confidential 
name-based reporting. In 2008, an estimated 
25% of adults and adolescents living with HIV
infection were female. Black and Latina women 
are disproportionately affected at all stages of 
HIV infection compared with women of other 
races/ethnicities. 
The Numbers 
New HIV Infections2 
In 2009, there were an estimated 11,200 new HIV
infections among women in the United States. That
year, women comprised 51% of the US population
and 23% of those newly infected with HIV. 
• Of the total number of new HIV infections in US
women in 2009, 57% occurred in blacks, 21% were
in whites, and 16% were in Hispanics/Latinas.
• In 2009, the rate of new HIV infections among 
black women was 15 times that of white 
women, and over 3 times the rate among 
Hispanic/Latina women. reflects HIV testing trends. 
HIV and AIDS Diagnoses3 and Deaths • Women accounted for more than 25% of the
estimated 34,247 AIDS diagnoses in 2009• At some point in her lifetime, 1 in 139 women
and represent nearly 20% of cumulative AIDSwill be diagnosed with HIV infection. Black and
diagnoses (including children) in the UnitedHispanic/Latina women are at increased risk of
States to date. There were 8,647 AIDS diagnosesbeing diagnosed with HIV infection (1 in 32 black
among women in 2009 compared with 9,639women and 1 in 106 Hispanic/Latina women will
AIDS diagnoses among women in 2006.be diagnosed with HIV, compared with 1 in 182
 
Native Hawaiian/other Pacific Islander women; • For women living with a diagnosis of HIV
 
1 in 217 American Indian/Alaska Native women; infection, the most common methods of 

and 1 in 526 for both white and Asian women). transmission were high-risk heterosexual 

contact6 and injection drug use.• From 2006 through 2009, estimated diagnoses
of HIV infection among women decreased from • In 2008, 4,796 (28%) of the estimated 17,374 
10,851 to 9,973. It is unknown whether this persons with a diagnosis of HIV infection who 
decrease is due to an actual decrease in new HIV died in the 40 states and 5 US dependent areas 
infections (incidence) or whether the decrease were women. Deaths attributed to HIV among 
1 Unless otherwise noted, this fact sheet defines women as adult and adolescent females aged 13 and older.
 
2 New HIV infections refers to HIV incidence, or the number of people that are newly infected with HIV.
 
3 HIV and AIDS diagnoses indicates when a person is diagnosed with HIV infection or AIDS but does not indicate when the person 

  was infected.
 
4 The term men who have sex with men (MSM) is used in CDC surveillance systems. It indicates the behaviors that transmit HIV   

  infection, rather than how individuals self-identify in terms of their sexuality.
 
5 IDU is an acronym for injection drug user.
 
6 Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
 
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 
Division of HIV/AIDS Prevention 
Source: Prejean J, et al. Estimated HIV incidence in the 
United States, 2006–2009. PLoS One 2011;6(8):1–13. 
Estimates of New HIV Infections,
by Race/Ethnicity, Risk Group, and Gender

































































































































Subpopulations representing 2 percent or less of the overall US epidemic 
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Additional Resources: 
CDC HIV and AIDS 
www.cdc.gov/hiv 
Visit CDC’s HIV and AIDS 
Web site. 
CDC-INFO 
1-800-CDC-INFO  or 
1-800 (232-4636) 
cdcinfo@cdc.gov 
Get information about 
personal risk, prevention, 
and testing. 
CDC National HIV 
Testing Resources 
www.hivtest.org 
Text your ZIP code to KNOW 
IT or 566948. 
Locate an HIV testing site 
near you. 










Locate resources on HIV 
and AIDS treatment and 
clinical trials. 
For more information, visit the 
CDC HIV Web site at www.cdc. 
gov/hiv 
women of color are disproportionately high: 
from 2000–2007, HIV infection was among 
the top 10 leading causes of death for black 
females aged 10–54 and Hispanic/Latina 
females aged 15–54. 
Prevention Challenges 
Like other affected populations, women face a 
number of risk factors that may contribute to 
their risk for HIV infection. 
• Most women are infected with HIV through 
heterosexual sex. Some women become 
infected because they may be unaware of a 
male partner’s risk factors for HIV infection 
or have a lack of HIV knowledge and lower 
perception of risk. Relationship dynamics 
also play a role. For example, some women 
may not insist on condom use because they 
fear that their partner will physically abuse 
or leave them. 
• Both unprotected vaginal and anal sex pose
a risk for HIV transmission. Unprotected
anal sex presents an even greater risk for HIV
transmission for women than unprotected
vaginal sex.
• Women who have experienced sexual
abuse may be more likely than women
with no abuse history to use drugs as a
coping mechanism, have diffi culty refusing
unwanted sex, exchange sex for drugs, or
engage in high-risk sexual activities. 
• Injection drug and other substance use
increase HIV risk through sharing injection
equipment contaminated with HIV or engaging
in high-risk behaviors, such as unprotected sex,
when under the influence of drugs or alcohol. 
• The presence of some sexually transmitted 
diseases greatly increases the likelihood 
of acquiring or transmitting HIV. Rates of 
gonorrhea and syphilis are higher among 
women of color than among white women. 
• Socioeconomic issues associated with poverty,
including limited access to high-quality health
care; the exchange of sex for drugs, money,
or to meet other needs; and higher levels
of substance use can directly or indirectly
increase HIV risk factors.
What CDC Is Doing 
CDC recognizes the importance of 
incorporating culture- and gender-relevant 
material into current HIV interventions. CDC 
has increased the availability of effective 
behavioral interventions for populations at 
increased risk for HIV infection, including 
women living with HIV infection or AIDS 
and those who are at risk for infection, 
by supporting research studies to develop 
new interventions and to adapt existing 
interventions. CDC also supports the national 
dissemination of effective HIV behavioral 
interventions for women. For example: 
• SIHLE (Sistering, Informing, Healing, 
Living, and Empowering) is a group-
level intervention aimed at reducing risk 
behaviors among sexually active black 
teenagers aged 14–18. 
• Sister to Sister is a brief, one-on-one, 
skills-based behavioral intervention for 
sexually active African American women 
aged 18 to 45 years to reduce sexual risk 
behaviors and prevent HIV and other 
sexually transmitted infections. 
• WILLOW (Women Involved in Life
Learning from Other Women) is a social-
skills building and educational intervention
for adult heterosexual women, aged 18 to 50
years, living with HIV infection. 
CDC also developed Take Charge. Take the
Test. (TCTT), a phase of the Act Against AIDS
campaign designed to increase HIV testing among
African American women aged 18–34.
CDC also continues to 
• Partner with organizations such as the Black
Women’s Health Imperative, Congressional
Black Caucus Foundation, and others to
address HIV among African American
women through the Act Against AIDS
Leadership Initiative; 
• Fund HIV testing and prevention programs 
in state and local health departments and 
community-based organizations; 
• Be actively involved in the research of 
microbicides—creams or gels that can be 
applied vaginally or anally before sexual 
contact to prevent HIV transmission; 
• Support clinical trials of pre-exposure
prophylaxis (PrEP), including a CDC trial in
Botswana which found that PrEP reduced the
risk of heterosexual transmission of HIV by
roughly 63% in the study group overall; and 
• Work to further reduce mother-to-child
HIV transmission in the US by supporting
perinatal HIV prevention campaigns,
enhanced surveillance for HIV-infected
mothers and babies, education programs, and
capacity building among health care providers
and public health practitioners. 
